Samsung Biologics has terminated its contract manufacturing organization (CMO) agreement with U.S. biotech CytoDyn early due to the latter's failure to develop new drugs and make an upfront payment, according to industry sources.In a corrected public filing on Monday last week, Samsung Biologics sai
A 30-year-old office worker surnamed Choi made a New Year's resolution to get in shape and joined a gym. Motivated, he watched YouTube videos and spent hours following the trainer's high-intensity workouts. After several days of repetition, he developed colored urine and severe muscle pain. Tests re
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent -- GC Cell, a notable player in the biotechnology field, is increasingly making its mark in the area of cell and gene therapy (CGT).Under the guidance of CEO James Park, who was appointed in March 2023, the company is acti
Pediatric clinics are busiest on Mondays, and, to help avoid an “opening rush” on the first day of the week, hospitals must strengthen holiday treatment, a report said.Rep. Shin Hyun-young of the Democratic Party of Korea has released the report based on her analysis of pediatric claims by day of th
VUNO, a Kosdaq-listed medical AI company, said Monday that its AI-based chest CT reading assistant solution, VUNO Med-Lung CT AI, has received approval for health insurance coverage in Japan.VUNO Med-Lung CT AI, which has been certified by Japan's Pharmaceutical and Medical Devices Agency (PMDA), is
S.Thepharm, an aesthetic products company that is a subsidiary of Kosdaq-listed S.Biomedics, said Monday that three of its hyaluronic acid fillers, Qtfill Signature, have received product licenses in Vietnam.Qtfill Signature consists of fillers used to improve facial wrinkles in adults through physi
Headaches are a common and familiar symptom in this modern world of stress and fatigue. “Migraines” are one of the most common headache disorders that cause the most visits to the doctor and impair quality of life.Most people don't think much of migraines because they often go away after a good rest
There were concerns about the potential cardiovascular risks associated with the long-term use of tenofovir alafenamide fumarate (TAF) in patients with chronic hepatitis B.However, a Korean study has confirmed this is not true.Asan Medical Center (AMC) said Friday that a team led by Professor Choi J
The supply shortage of AstraZeneca Korea’s migraine treatment Zomig (zolmitriptan) Tab. has occurred again.According to the Ministry of Food and Drug Safety (MFDS), AstraZeneca reported a shortage of Zomig 2.5mg on Thursday. Zomig is a selective 5-HT receptor agonist and is licensed in Korea for the
Pharmgen Science said Friday that it has received approval from the Ministry of Food and Drug Safety (MFDS) for Pharmgen Covid/Flu A&B Antigen Combo, a kit for the simultaneous diagnosis of Covid-19 and influenza A and B viruses.The combo kit is a diagnostic device that detects covid-19 and influenz
365mc, a medical institution specializing in obesity care, said Friday that it signed an agreement with a cloud/AI company, Naver Cloud, to build a smart hospital capable of AI-based obesity treatment.A smart hospital is optimized for the safety and convenience of patients and medical staff through
ViGenCell said Thursday that a study demonstrating the world's first direct therapeutic effect on atopic dermatitis using cord blood-derived myeloid suppressor (CBMS) cells has been published in an SCI-ranked journal.The study, "Skin Repair and Immunoregulatory Effects of Myeloid Suppressor Cells fr
On Tuesday, a tragedy occurred in Taean, South Chungcheong Province, where the parents of a nine-year-old girl with juvenile diabetes committed suicide.At a parliamentary debate two days later, experts pointed out that continuous glucose monitors and insulin injectors, such as insulin pumps and digi
Daiichi Sankyo and AstraZeneca Korea's new antibody-drug conjugate (ADC) drug Enhertu 100 mg (trastuzumab deruxtecan) has been rejected by the Pharmaceutical Reimbursement Evaluation Committee.The Health Insurance Review and Assessment Service (HIRA) held this year’s first Pharmaceutical Reimburseme
Celltrion said Friday that its biosimilar products for autoimmune diseases are continuing to make an impact, winning bids in key European countries.First, Celltrion said that Yuflyma won state bids for adalimumab in Friuli-Venezia Giulia (FVG) and Sicilia, Italy, securing to provide Yuflyma for four
Ilooda, a Kosdaq-listed medical device company specializing in skin aesthetics, said Thursday that it has obtained approval in Russia for its skin-tightening device, Hyzer Me.Hyzer Me is a medical device that applies high-intensity focused ultrasound (HIFU) for skin-tightening, equipped with an ultr
Abdominal inflation, a feeling of gas in the intestines that causes the stomach to swell like a balloon, is a common symptom of many digestive diseases. It can be a symptom of stomach or colon cancer, and certain foods with lactose intolerance or carbohydrate intolerance can also cause it."The first
Korea's first "infectious disease hospital" will begin construction in the first half of this year.The Korea Disease Control and Prevention Agency (KDCA) said Thursday that it would build a hospital specializing in infectious diseases at Chosun University Hospital through public bidding. The bidding
Ono Pharmaceutical Korea said Thursday that Braftovi (encorafenib), a targeted therapy for BRAF V600E-mutated metastatic colorectal cancer, has been approved for health insurance coverage effective Jan. 1.The reimbursement will be available in combination with cetuximab for patients with metastatic
LG Chem said Thursday that it will co-market Kyowa Kirin’s Nephoxil (ferric citrate hydrate), a hyperphosphatemia drug, for patients with chronic kidney disease undergoing hemodialysis in Korea. Hyperphosphatemia is a disorder of electrolyte metabolism caused by abnormal kidney function that can lea